← All organizations
Hutchison MediPharma
For profitWebsite ↗
Also known as: HMPL | HMP MediPharma Ltd. | Huchison Medipharma Limited | Hutchinson MediPharma (HMP) | Hutchison | Hutchison MediPharma | Hutchison Medi Pharma | Hutchison MediPharma International | Hutchison Medipharma Limited | Hutchison Medipharma Ltd. | Hutchison MediPharma Ltd | Hutchison Medipharm Limited
Highest phase reached
Phase 4
First clinical trial
Apr 1, 2006Last known activity
May 25, 2024
Timeline
2000s
- Jun 1, 2002
Hutchison MediPharma— Founded
Drugs by trial phase (43 distinct, 102 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (13 own, 0 via acquisition)
Indications
Studied for
- Arthritis
- Arthritis, Rheumatoid
- Bile Duct Neoplasms
- Biliary Tract Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Renal Cell
- Cholangiocarcinoma
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Colorectal Neoplasms
- Crohn Disease
- Glioblastoma
- Inflammatory Bowel Diseases
- Kidney Diseases
- Kidney Neoplasms
- Leukemia
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Mesothelioma
- Neoplasms
- Neoplasms by Site
- Neuroendocrine Tumors
- Purpura, Thrombocytopenic, Idiopathic
- Stomach Neoplasms
- Thrombocytopenia
- Thyroid Diseases
- Thyroid Neoplasms
- Triple Negative Breast Neoplasms
- Ulcer
- Urologic Neoplasms
Recent trials (50)
- NCT04814732Study chairN/A—
- NCT04814732Lead sponsorN/A—
- NCT06437353CollaboratorPhase 2May 25, 2024
- NCT05842525CollaboratorPhase 2Oct 1, 2023
- NCT05886374Study directorPhase 1Jul 6, 2023
- NCT05713110Study directorPhase 2Feb 13, 2023
- NCT05522231Lead sponsorPhase 2/Phase 3Oct 31, 2022
- NCT05535933Lead sponsorPhase 2/Phase 3Sep 30, 2022
- NCT05509699Lead sponsorPhase 2Aug 31, 2022
- NCT05522738CollaboratorPhase 1/Phase 2Aug 31, 2022
- NCT05467943Lead sponsorPhase 2Jul 29, 2022
- NCT05318820Lead sponsorEarly Phase 1Apr 30, 2022
- NCT05176691Study directorPhase 1Feb 15, 2022
- NCT05511051CollaboratorPhase 2Feb 1, 2022
- NCT05173142Lead sponsorPhase 1/Phase 2Jan 22, 2022
Details
- Founded
- Shanghai, CN Jun 1, 2002
- Last known activity
- May 25, 2024